Publication | Closed Access
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
34
Citations
111
References
2025
Year
Cancer ImmunosurveillanceOncologyMedicineImmunologyImmune Checkpoint InhibitorDistinct Clinical OutcomesCancer TreatmentImmunotherapyPharmacologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1